Alira Health

Silicon Valley Bank Leads Group of Sponsors Funding LabCentral Ignite Programs to Support Underrepresented Life Sciences Entrepreneurs

Wilson Sonsini Goodrich & Rosati, EisnerAmper, and Alira Health part of group sponsoring LabCentral Ignite’s 2023 Golden Ticket competition and fellowship program supporting diverse founders in the life sciences

News
Published on:
February 23, 2023

CAMBRIDGE, Mass., Feb. 23, 2023 — Silicon Valley Bank has assembled a diverse group of organizations, including Wilson Sonsini Goodrich & Rosati, EisnerAmper, and Alira Health, to sponsor LabCentral Ignite, a first-and-only-of-its-kind platform to address systemic racial, gender, and other underrepresentation in talent across the life sciences and biotech industry.

In addition to their banking, legal, accounting, and healthcare consulting expertise for the life sciences industry, the financial contribution from these sponsors will support Ignite’s entrepreneur programming, such as the LabCentral Ignite Golden Ticket competition and the accompanying Ignite Fellowship.

The LabCentral Ignite Golden Ticket contest was designed to support biotech entrepreneurs who identify as women, Black, Latinx, Indigenous, or other persons of color who are using innovative science to solve human health problems. Winners receive free access to LabCentral’s shared lab space in Cambridge. In addition, winners participate in a year-long Ignite Fellowship program that aims to supercharge their networks, connecting these entrepreneurs to top investors, partners, advisors, and mentors.

“As Ignite enters our third year, we remain dedicated to amplifying the voices and expanding opportunities for those who have historically been excluded from this industry so they can focus on changing the world through groundbreaking science. Thanks to the support of Silicon Valley Bank, Wilson Sonsini Goodrich & Rosati, EisnerAmper, and Alira Health, who believe in our mission, we can support more underrepresented entrepreneurs with the potential to significantly impact biotech and the life sciences,” said Gretchen Cook-Anderson, LabCentral Ignite’s Executive Director.

“At Silicon Valley Bank, we know that diverse perspectives and inclusive environments ignite new ideas and power innovation,” said Anton Xavier, Director, SVB Startup Banking. “The LabCentral Ignite program spotlights often overlooked communities in biotech and life sciences and creates opportunities to foster a culture of inclusion in the industry.”

The 2023 LabCentral Ignite Golden Ticket contest will launch later this year. Candidates will be reviewed based on the quality and potential impact of their science along with other standard selection criteria. A select number of finalists will receive access to coaching and will be invited to present at a pitch event in September during Global Biotech Week, which draws industry professionals and investors to life sciences events around the world. Following the pitch contest, the winning companies will be awarded Ignite Golden Tickets.

About LabCentral Ignite

The growing Ignite platform is dedicated to developing equity, inclusion, and opportunity within the life sciences field. Through a range of equity-driven programs and a growing member network of industry, startups, higher education, and nonprofits, Ignite connects underrepresented students, talent and innovators to academic, technical skills-building, mentoring, job placement, and board and leadership preparation opportunities that fuel biotech diversity and inclusively transform careers. More information is available at www.labcentralignite.org.

About LabCentral

LabCentral is a network of laboratory spaces and scientific communities, purposed designed to jumpstart the launch of promising early-stage life-sciences companies. Providing first-class operational support, curated events and programming, and access to a diverse network of sponsors, LabCentral prepares entrepreneurs and scientists to accelerate scientific innovation in service of human health. More information is available at www.labcentral.org.

Related news

Events March 31, 2025
Swiss Biotech Day 2025
Connect with our delegates on-site to discover how we can assist you with our agile and holistic biotech solutions.
Biotech EU
Events March 12, 2025
Healthtech Accelerations Summit 2025
Meet our experts to discover how we support companies bring innovation to patients by structuring drug development into clear, achievable inflection points.
Biotech Drug Development EU Healthcare Technology
Events February 18, 2025
BIO-Europe Spring 2025
Learn how can we support your planning, funding, and executing processes, both strategically and technically, to successfully bring your innovation to patients.
Biotech EU
Events February 17, 2025
German Biotech Days 2025
Meet us during the German Biotech Days to discuss how we can advance biotech innovation together.
Biotech EU
Events January 31, 2025
2024 BioRegion Report Presentation
Learn how can we help at every stage of your product lifecycle, from drug development process to market access, pricing and reimbursement strategies.
Biopharma Biotech EU
News December 17, 2024
Alira Health Secures Up to $100M Growth Debt Facility from Symbiotic Capital to Propel Strategic Expansion and Patient-Enabled Innovation
This funding will drive Alira Health’s strategic growth, enhance its innovative technology platforms, and support solutions that empower patients and create value for life sciences companies.
Biopharma Life Sciences MedTech Patient-Enabled Innovation Strategic Expansion
Articles December 16, 2024
2024 Recap: Your Favorite Alira Health Publications
As we wrap up 2024, we’re sharing Alira Health's top ten most popular publications with you.
Life Sciences Patient Engagement
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.